In current practice, gadolinium-based contrast agents have been considered safe when used at clinically recommended doses in patients without severe renal insufficiency. The causal relationship between gadolinium-based contrast agents and nephrogenic systemic fibrosis in patients with renal insuffic...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!